Tillotts Pharma Ag competitive analysis

Explore patent oppositions filed by Tillotts Pharma Ag against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Controlled-Release Granular Compositions Containing Mesalazine And Process For The Manufacture ThereofSOFARFeb 28, 2019
Mesalazine Tablet Having Improved DissolutionDISPHARNov 21, 2018
Antibodies With Modified Affinity To Fcrn That Promote Antigen ClearanceCHUGAI SEIYAKU KABUSHIKI KAISHAFeb 5, 2018
Granules For Pharmaceutical Preparations, Methods And Apparatus For Their ProductionFERRINGAug 9, 2017
Novel Dispersible Tablet CompositionRUBICON RESEARCH PRIVATEJul 19, 2017
Ph-Controlled Pulsatile Delivery System, Methods For Preparation And Use ThereofSTICHTING GRONINGEN CENTRE FOR DRUG RESEARCHJul 25, 2016

Explore Tillotts Pharma Ag's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Nov 23, 2022Preparation Of Solid Dosage Forms Comprising Antibodies By Solution/Suspension Layering1

Latest PTAB cases involving Tillotts Pharma Ag

Discover the latest PTAB cases involving Tillotts Pharma Ag, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Tillotts Pharma Ag with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TILLOTTS PHARMA AG61 - -
CHUGAI SEIYAKU KABUSHIKI KAISHA3117 - 1
DISPHAR - 1 - -
FERRING822 - -